Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,270.5
10.4 (0.32%)

 

  • STI Straits Times Index
    3,270.5
    10.4 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,519.1
    3.1 (0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,541.1
    -265.9 (-1.12%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,367.1
    -27.1 (-0.80%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 261.7M
  • Value: 535.4M
  • Rise: 111
  • Fall: 106
  • Unch: 551

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.082-
Genting Sing0.730+0.005
AusGroup0.020-0.001
Singtel2.480-0.020
Keppel Corp5.670+0.380
Thomson Medical0.083+0.002
Jiutian Chemical0.084+0.001
UMS1.210+0.010
CapLand IntCom T1.970+0.010
Mapletree Com Tr1.830-0.020

World Indices

World Indices
Name Last Change
Nasdaq 13,352.8 -189.3
HSI 23,652.5 -154.5
HSCEI 8,236.4 -55.0
Jakarta 6,619.0 +7.9
Nikkei 225 26,170.3 -841.0
SSE Comp 3,394.8 +0.5
Shanghai A 3,557.5 +0.5
Shanghai B 281.3 +2.2
KOSPI 2,650.5 +36.0

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ADVENTA ADVENTA BHD
Quotes 15 Minutes Delayed. Updated at 28 Jan 2022 11:10
Last (MYR): 0.890 Change: - High: 0.900 Remarks:
Change (%): - Low: 0.875
Open 0.875 Yesterday's Close 0.890
Buy Price 0.890 Sell Price 0.895
Buy Volume ('00) 100 Sell Volume ('00) 14
Cumulative Volume ('00) 1,058 Cumulative Value 94,940

Company Background

The ADVENTA group is principally involved in the manufacture and distribution of medical products and devices for the healthcare industry.

The group�s workforce is over 1100 strong and are located in 4 countries.

In June 2004, ADVENTA was listed on the Malaysian Stock Exchange, Bursa Malaysia.

The subsidiaries of ADVENTA are committed to strong, sustained growth within their disciplines. The means to this are product excellence and employee commitment to customers.

The group is continuously sourcing for talents that can add strength and contribute ideas to the organization. ADVENTA intends to create value and returns through the implementation and commercialization of its ideas and innovations.

Click to show Stock Prices chart

Key Statistics

EPS (MYR) a -0.07709 Trailing EPS (MYR) b -0.00109 NAV (MYR) c 0.4213
PE a - Trailing PE d - Price / NAV c 2.1125
Dividend Yield (%) e - Cash In Hand (MYR) f 0.0898 Issued & Paid-up Shares g 152,786,000
Piotroski F Score 3 Market Cap (M) 135.980 Free Float (%) 51.1
Return on Equity (ROE) (%) h n.m. Revenue Growth (%) TTM i 3.474
Net Earnings Growth (%) j 98.127 Net Debt/Equity k Net Cash
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia Fledgling Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 28 Sep 2020. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.050
-5.32 %
10 Days --0.120
-11.88 %
20 Days --0.180
-16.82 %
Medium Term Return 3 Months --0.015
-1.66 %
6 Months --0.830
-48.26 %
1 Year --0.630
-41.45 %
Long Term Return 2 Years -+0.050
+5.95 %
3 Years 0.070+0.552
+184.02 %
5 Years 0.070+0.300
+62.71 %
Annualised Return Annualised --
+10.23 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ADVENTA Bursa 135.980 - - 2.1125 -
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 5,572.592 2.863 2.491 2.0058 16.864
Medical Specialties Bursa 6,628.235 2.767 2.752 2.2500 17.748
Index BM HEALTH CARE Bursa 6,509.082 6.872 5.538 2.2185 7.256
FTSE Bursa Malaysia Fledgling Index Bursa 252.553 50.612 33.191 1.0413 1.099
Local Peer HARTA Bursa 19,035.263 6.597 3.595 2.8133 9.174
Local Peer TOPGLOV Bursa 16,650.122 2.159 3.016 2.9680 31.306
Local Peer SUPERMX Bursa 3,218.785 0.843 0.878 0.6439 3.090
Local Peer RGTBHD Bursa 541.929 54.092 78.700 5.3789 -
Local Peer LKL Bursa 76.688 - - 0.5232 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 218,200.140 34.227 25.476 5.6368 0.160
Global Peer ABBOTT LABORATORIES NYSE 212,972.848 47.613 - - -
Global Peer DANAHER CORP NYSE 192,914.353 54.961 33.714 4.8009 0.265
Global Peer MEDTRONIC PLC NYSE 138,731.701 38.472 29.486 2.6684 2.347
Global Peer INTUITIVE SURGICAL INC NASDAQ 93,801.532 55.029 55.028 7.8485 -
Global Peer STRYKER CORP NYSE 92,548.289 57.879 48.710 6.5276 0.957
Global Peer BECTON DICKINSON & CO NYSE 71,599.951 35.764 35.764 3.0243 1.335
Global Peer EDWARDS LIFESCIENCES CORP NYSE 63,657.095 77.310 43.090 11.4878 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 61,602.318 - 59.119 3.7421 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,373.649 38.452 34.904 4.8317 1.138
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), ALCON AG (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), STERIS PLC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), PERKINELMER INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), MASIMO CORPORATION (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), GLOBUS MED INC (NYSE), NOVOCURE LTD (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), SHANDONG WEIGAO GROUP MEDICAL (HKEx), MICROPORT SCIENTIFIC CORPORATION (HKEx), ICU MEDICAL INC (NASDAQ), EBOS GROUP (ASX), SHOCKWAVE MEDICAL INC (NASDAQ), STEVANATO GROUP S.P.A. (NYSE), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), QUIDEL CORP (NASDAQ), LIVANOVA PLC (NASDAQ), Top Glove (SGX), NEOGEN CORP (NASDAQ), ANGELALIGN TECHNOLOGY INC (HKEx), CONMED CORP (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), LUMIRADX LTD (NASDAQ), NEVRO CORP (NYSE), GLAUKOS CORPORATION (NYSE), AXONICS INC (NASDAQ), CAREDX INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), OUTSET MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), AVANOS MEDICAL INC (NYSE), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CUE HEALTH INC (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), PARAGON 28 INC (NYSE), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), VAREX IMAGING CORPORATION (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), TREACE MED CONCEPTS INC (NASDAQ), BIOVENTUS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), BUTTERFLY NETWORK INC (NYSE), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), CERUS CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), VIEWRAY INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ARTIVION INC (NYSE), VICARIOUS SURGICAL INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), SI BONE INC (NASDAQ), INOGEN INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), INTERCURE LTD (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), IRADIMED CORP (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), SISRAM MEDICAL LTD (HKEx), METRICS INCOME OPPORTUNITIES TRUST (ASX), BRONCUS HOLDING CORPORATION (HKEx), TRANSMEDICS GROUP INC (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), 908 DEVICES INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), APYX MEDICAL CORPORATION (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ACCURAY INCORPORATED (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), UTAH MEDICAL PRODUCTS (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), DERMTECH INC (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ZYNEX INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), SHANGHAI CONANT OPTICAL CO LTD (HKEx), FLUIDIGM CORP DEL (NASDAQ), NEUROPACE INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PW MEDTECH GROUP LIMITED (HKEx), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), AROA BIOSURGERY LTD (ASX), CLEARPOINT NEURO INC (NASDAQ), IMPEDIMED LIMITED (ASX), PROFOUND MED CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), SONENDO INC (NYSE), EARGO INC (NASDAQ), QUOTIENT LTD (NASDAQ), TELA BIO INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CORMEDIX INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), SIENTRA INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INTRICOM CORP (NASDAQ), DARIOHEALTH CORP (NASDAQ), MINERVA SURGICAL INC (NASDAQ), PAVMED INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), UGHealthcare (SGX), Medtecs Intl (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CONFORMIS INC (NASDAQ), FONAR CORP (NASDAQ), ELECTROMED INC (NYSE American), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), NEURONETICS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), INVACARE CORP (NYSE), IRIDEX CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SDI LTD (ASX), VENUS CONCEPT INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), ICECURE MEDICAL LTD (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), MICRO-X LTD (ASX), KELFRED HOLDINGS LTD (HKEx), VOLITIONRX LIMITED (NYSE American), ALPHA PRO TECH (NYSE American), REWALK ROBOTICS LTD (NASDAQ), IMMUCELL CORP (NASDAQ), TITAN MEDICAL INC (NASDAQ), OPTISCAN IMAGING (ASX), LENSAR INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ENVVENO MED CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DIMERIX LTD (ASX), RESONANCE HEALTH LTD (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), INTEGRITY APPLICATIONS INCORPORATIO (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROCORE INC (NASDAQ), COMPUMEDICS (ASX), DELCATH SYSTEMS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), NEPHROS INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), CARDIEX LTD (ASX), KEWAUNEE SCIENTIFIC CORP (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), ROCKWELL MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), Yunnan Energy (SGX), BLUEJAY DIAGNOSTICS INC (NASDAQ), Biolidics (SGX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NUTRIBAND INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), NEUROMETRIX INC (NASDAQ), NEOVASC INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), RESPIRI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), AETHLON MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NANOVIBRONIX INC (NASDAQ), LBT INNOVATIONS LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), APPLIED UV INC (NASDAQ), ADHERIUM LIMITED (ASX), INSPIREMD INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), TRUSCREEN GROUP LTD (ASX), PETVIVO HLDGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), CYANOTECH CORP (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), HEARTBEAM INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), METALICITY LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), OVENTUS MEDICAL LTD (ASX), Annica (SGX), SINTX TECHNOLOGIES INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), VIVEVE MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RA MEDICAL SYSTEMS INC (NYSE American), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.